Info day – 15 May 2025 in Paris

Pharmaceutical Industry and Nitrosamines: from Risk Assessments to Control Strategies

organized with

The Introduction will open the day by addressing the context and regulatory environment
• Approach to excipient-related aspects (starch and MCC)
• Quality management approach
• Challenges in the analytical dosing of nitrosamines in excipients
• Risk analysis and strategies used by the Pharmaceutical Industry to avoid analytical dosage of nitrosamines (case studies on active ingredients APIs and finished dosage forms FDF)